<?xml version="1.0" encoding="UTF-8"?>

<!-- This is a Bundle of Bundles, each of which is a document (having a Composition, and supporting resources) -->
<!-- 2020-02-02 -->
<!-- This is for FHIR version R5 Preview 2 (May 2020) -->
<!-- This file uses relative links between resorces e.g. "Resource/id". Some servers require uuid references (to fullUrl) when saving bundles
     which are shown with comments -->
<!-- todo a solution for Blue Box (or two variants) -->
<Bundle xmlns="http://hl7.org/fhir">
	<type value="collection"/>
   <!-- Repeat at this level per document -->
   <!-- Document 1-->
	<entry>
		<fullUrl value="urn:uuid:1b575a0b-3bc8-499f-9852-2da9f8e5a908"/>
			<!-- Top level of each document is a FHIR Bundle, of type "document" 
			 see http://hl7.org/fhir/documents.html, http://hl7.org/fhir/bundle.html.
		 	All the other resources are within this. -->
		<resource>
        	<Bundle><!-- When PUTing, some servers mandate an id here to match the existing id -->
				<id value="709f4405-9739-43d8-b888-d48702930f96"/> <!--When PUTing, some servers mandate an id here to match the existing id -->
            <!-- document bundles must have an identifier (bdl-9) -->
				<identifier><!-- document bundles must have an identifier (bdl-9) -->
               <system value="http://ema.europa.eu/fhir/identifier/documentid"/>
					<!-- example identifier  -->
					<value value="KAL-Auth-999"/>
				</identifier>
            	<!-- fixed code -->
				<type value="document" />
            	<!-- document bundles must have a date (bdl-10) -->
            	<timestamp value="2020-02-01T10:10:10Z"/>
				<!-- a repeating set of entry elements, each with a FHIR resource -->
				<entry>					<!-- fullUrl is mandatory for each entry in document Bundle. It is a random uuid. http://build.fhir.org/bundle.html#bundle-unique -->
					<fullUrl value="urn:uuid:1195d0c6-2db9-4017-8ae3-c8a90137e83d"/>
					<resource>
						<!-- the first resource must be Composition (bdl-11) -->
						<!-- This is the overall document structure. -->
						<!-- see definition http://hl7.org/fhir/composition.html, and similar for other resources -->
						<!-- based on https://www.ema.europa.eu/en/medicines/human/EPAR/kalydeco#authorisation-details-section -->
                        <Composition>
							<!--text>
								<status value="additional"/>
								<div xmlns="http://www.w3.org/1999/xhtml">Optional pre-rendered html text of the whole thing</div>
							</text-->
							
							<status value="final"/> <!-- fixe2f3e3d value (unless we want to support drafts) -->
							<type>
								<coding>
									<!-- fixed system, code and display -->
									<system value="http://spor.ema.europa.eu/v1/lists/100000155531"/>
									<code value="100000155537"/> <!-- it is good practice to show the display, even though it is implied by the code -->
									<display value="Other Product Information"/> <!-- want a proper code for this -->
								</coding>
							</type>
							<subject>
                        		<reference value="List/SmPCProductsKalydeco1"/>
								<!--reference value="urn:uuid:812a430c-0eda-4615-a30b-a760edaa3597"/--> <!-- links to the List resource in this bundle -->
								<!-- List/SmPCProductsKalydeco -->
							</subject>
                     	   <date value="2020-02-01"/>
							<author>
								<identifier>
									<system value="http://spor.ema.europa.eu/v1/locations" />
									<value value="LOC-10001868" /> <!-- example system and data. A EMA OMS hosted identifier -->
								</identifier>
							</author>
							<title value="Authorisation details"/>
							<section>
								<title value="Product Details"/>
								<code>
									<coding>
										<!-- sections will all have codes to identify them -->
										<!-- the codes are not yet available, and will need to be configurable -->
										<system value="http://spor.ema.europa.eu/v1/example-sections"/> <!-- example code system -->
										<code value="00000021213"/> <!-- example code, a defined list will be needed - to be confirmed -->
										<display value="Authorisaton Section"/>
									</coding>
								</code>
								<text>
									<status value="additional"/>
									<div xmlns="http://www.w3.org/1999/xhtml">
										<!-- any xhtml is valid here, with a few exceptions 
										                                          (e.g. head, body, scripts etc). 
										                                          See http://hl7.org/fhir/narrative.html#Narrative -->
										<table class="ecl-table">
											<tbody>
												<tr class="odd">
													<td>Name</td>
													<td>Kalydeco</td>
												</tr>
												<tr class="even">
													<td>Agency product number</td>
													<td>EMEA/H/C/002494</td>
												</tr>
												<tr class="odd">
													<td>Active substance</td>
													<td>ivacaftor</td>
												</tr>
												<tr class="even">
													<td>International non-proprietary name (INN) or common name</td>
													<td>ivacaftor</td>
												</tr>
												<tr class="odd">
													<td>Therapeutic area (MeSH)</td>
													<td>Cystic Fibrosis</td>
												</tr>
												<tr class="even">
													<td>Anatomical therapeutic chemical (ATC) code</td>
													<td>R07AX02</td>
												</tr>
												<tr class="odd">
													<td>Accelerated assessment</td>
													<td>This medicine had an 
														<a href="https://www.ema.europa.eu/en/glossary/accelerated-assessment"
                                             				title="Rapid assessment of medicines in the centralised procedure that are of major interest for public health, especially ones that are therapeutic innovations. Accelerated assessment usually takes 150 evaluation days, rather than 210. More information can be found under 'Accelerated assessment'.">accelerated assessment</a>.
															This means that it is a medicine of major interest for public health, so its timeframe for review was 150 evaluation days rather than 210. For more information, see 
														<a href="https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation/accelerated-assessment">Accelerated assessment</a>.
													</td>
												</tr>
												<tr class="even">
													<td>Orphan</td>
													<td>This medicine was designated an 
														<a href="https://www.ema.europa.eu/en/glossary/orphan-medicine"
                                             			title="A medicine for the diagnosis, prevention or treatment of a life-threatening or chronically debilitating condition that is rare (affecting not more than five in 10,000 people in the European Union) or where the medicine is unlikely to generate sufficient profit to justify research and development costs. More information can be found under 'Orphan designation -  Overview'.">orphan medicine</a>.
														This means that it was developed for use against a rare, 
														life-threatening or chronically debilitating condition or, 
														for economic reasons, it would be unlikely to have been developed without incentives. 
														For more information, see
                                                        <a href="https://www.ema.europa.eu/en/human-regulatory/post-authorisation/orphan-designation-post-authorisation">Orphan designation</a>.
													</td>
												</tr>
											</tbody>
										</table>
									</div>
								</text>
							</section>
							<!-- sections can repeat as necessary -->
						</Composition>
					</resource>
				</entry>
				<entry>
					<fullUrl value="urn:uuid:812a430c-0eda-4615-a30b-a760edaa3597"/>
					<resource>
                        <List>
							<!-- any id will do -->
                     	   <id value="SmPCProductsKalydeco1"/>
							<status value="current"/>
							<mode value="working"/>
							<entry>
								<item>
									<!-- TODO make this a "real" PMS id -->
									<!--reference value="https://pms-msfhir-r5-p2-sit.azurewebsites.net/MedicinalProductDefinition/600000450290"/-->
									<reference value="MedicinalProductDefinition/Kalydeco75"/>
									<!--reference value="urn:uuid:6916263f-f04d-4115-be23-b9a840e2f3e3"/-->
									<display value="Kalydeco 75 mg film-coated tablets"/>
									<!-- todo how refs will work -->
								</item>
							</entry>
							<entry>
								<item>
									<reference value="MedicinalProductDefinition/Kalydeco150"/>
									<!--reference value="urn:uuid:6916263f-f04d-4115-be23-b9a840e2f3e4"/-->
									<display value="Kalydeco 150 mg film-coated tablets"/>
								</item>
							</entry>
						</List>
					</resource>
				</entry>
			</Bundle>
		</resource>
	</entry>
	<entry>
      <fullUrl value="urn:uuid:e229e00c-5eae-4905-a644-98aae00aa26b"/>
      <!-- Top level of each document is a FHIR Bundle, of type "document" 
			 see http://hl7.org/fhir/documents.html, http://hl7.org/fhir/bundle.html.
		 	All the other resources are within this. -->
		<resource>
            <Bundle>
            <id value="aa7e0516-0d8c-4c24-8642-ce6f2e7dbfd3"/>
				<identifier>
					<!-- document bundles must have an identifier (bdl-9) -->
               <system value="http://ema.europa.eu/fhir/identifier/documentid"/>
					<!-- example identifier  -->
					<value value="KAL999"/>
				</identifier>
				<type value="document" /> <!-- fixed code -->
				<timestamp value="2021-02-01T10:10:10Z"/> 
				<!-- a repeating set of entry elements, each with a FHIR resource -->
				<entry>
					<!-- fullUrl is mandatory for each entry in document Bundle. It is a random uuid. http://build.fhir.org/bundle.html#bundle-unique -->
               <fullUrl value="urn:uuid:0c5bcdf8-f236-415a-96ca-1355942b0868"/>
					<resource>
						<!-- the first resource must be Composition (bdl-11) -->
						<!-- This is the overall document structure. -->
						<!-- see definition http://hl7.org/fhir/composition.html, and similar for other resources -->
                        <Composition>
							<contained>
                                <Binary>
                                	<id value="imageResource1"/>
                                	<contentType value="image/png"/> <!-- example format -->
									<!-- data is base 64 encoded, actual bytes of the image png file -->
									<data value="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"/>
								</Binary>
							</contained>
							<contained>
                                <Binary>
                                	<id value="imageResource2"/>
                                	<contentType value="image/png"/> <!-- example format -->
									<!-- data is base 64 encoded, actual bytes of the image png file -->
									<data value="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"/>
								</Binary>
							</contained>
							<!-- If there is a contained resource that is not referenced by its container, servers may reject this.
								 Servers may not recognise that it is referenced by id, from the text.
								 This extension ensures there is a reference to the contained Binary that servers can see -->
                        	<extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#imageResource1"/>
                        		</valueReference>
                        	</extension>
                        	<extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#imageResource2"/>
                        		</valueReference>
                        	</extension>
							<status value="final"/> <!-- fixed value (unless we want to support drafts) -->
							<type>
								<coding>
									<!-- fixed system, code and display -->
									<system value="http://spor.ema.europa.eu/v1/lists/100000155531"/>
									<code value="100000155532"/>
									<!-- it is good practice to show the display, even though it is implied by the code -->
									<display value="Summary of Product Characteristics"/>
								</coding>
							</type>
                        	<subject>
                        		<!-- <reference value="List/SmPCProductsKalydeco2"/> -->
                        		<reference value="urn:uuid:812a430c-0eda-4615-a30b-a760edaa3597"/> <!-- links to the List resource in this bundle -->
                        			<!-- List/SmPCProductsKalydeco -->
                        	</subject>
                     	   <date value="2021-02-01"/>
							<author>
								<identifier>
									<!-- example system and data. A EMA OMS hosted identifier -->
									<system value="http://spor.ema.europa.eu/v1/locations" />
									<value value="LOC-10001868" />
								</identifier>
							</author>
							<title value="ANNEX 1 - SUMMARY OF PRODUCT CHARACTERISTICS"/>
							<relatesTo>
								<code value="appends"/>
								<targetReference>
									<reference value="urn:uuid:1195d0c6-2db9-4017-8ae3-c8a90137e83d"/> <!-- reference to another Composition -->
									<!--reference value="Composition/id"/--> <!-- alternative form -->
								</targetReference>
							</relatesTo>
							<section>
								<!-- main sections of the document, to follow the QRD template (headings below are just examples) -->
								<title value="1. NAME OF THE MEDICINAL PRODUCT"/>
								<code>
									<coding>
										<!-- sections will all have codes to identify them -->
										<!-- the codes are not yet available, and will need to be configurable -->
										<system value="http://spor.ema.europa.eu/v1/example-sections"/>
										<!-- example code system -->
										<code value="00000021212"/>
										<!-- example code, a defined list will be needed - to be confirmed -->
										<display value="Name Section"/>
									</coding>
								</code>
								<text>
									<status value="additional"/>
									<div xmlns="http://www.w3.org/1999/xhtml">
										<div>Kalydeco 75 mg film-coated tablets</div>
										<div>Kalydeco 150 mg film-coated tablets</div>
									</div>
								</text>
							</section>
							<section>
								<title value="2. QUALITATIVE AND QUANTITATIVE COMPOSITION"/>
								<code>
									<coding>
										<system value="http://spor.ema.europa.eu/v1/example-sections"/>
		                              <code value="00000021212"/>
		                              <display value="Composition"/>
									</coding>
								</code>
								<text>
									<status value="additional"/>
									<div xmlns="http://www.w3.org/1999/xhtml">
										<div style="text-decoration:underline">
											<p>Kalydeco 75 mg film-coated tablets</p>
										</div>
										<div>
											<p>Each film-coated tablet contains 75 mg of ivacaftor.</p>
										</div>
										<div style="font-style: italic">
											<p>Excipient with known effect</p>
										</div>
										<div>
											<p>Each film-coated tablet contains 83.6 mg of lactose monohydrate.</p>
										</div>
										<div style="text-decoration:underline">
											<p>Kalydeco 150 mg film-coated tablets</p>
										</div>
										<div>
											<p>Each film-coated tablet contains 150 mg of ivacaftor.</p>
										</div>
										<div style="font-style: italic">
											<p>Excipient with known effect</p>
										</div>
										<div>
											<p>Each film-coated tablet contains 167.2 mg of lactose monohydrate. For the full list of excipients, see section 6.1.</p>
										</div>
									</div>
								</text>
							</section>
							<section>
								<title value="3. PHARMACEUTICAL FORM"/>
								<code>
									<coding>
										<system value="http://spor.ema.europa.eu/v1/example-sections"/>
                              		  <code value="00000031313"/>
                               		 <display value="Form"/>
									</coding>
								</code>
								<text>
									<status value="additional"/>
									<div xmlns="http://www.w3.org/1999/xhtml">
										<div>
											<p>Film-coated tablet (tablet)</p>
										</div>
										<div style="text-decoration:underline">
											<p>Kalydeco 75 mg film-coated tablets</p>
										</div>
										<div>
											<p>Light blue, capsule-shaped film-coated tablets, printed with “V 75” in black ink on one side and plain on the other (12.7 mm x 6.8 mm in modified tablet shape).</p>
										</div>
										<div style="text-decoration:underline">
											<p>Kalydeco 150 mg film-coated tablets</p>
										</div>
										<div>
											<p>Light blue, capsule-shaped film-coated tablets, printed with “V 150” in black ink on one side and plain on the other (16.5 mm x 8.4 mm in modified tablet shape).</p>
										</div>
										<table>
											<tr>
												<th>Heading 1</th>
												<th>Heading 2</th>
											</tr>
											<tr>
												<td>Some text</td>
												<!-- possible to link images to embedded Binary resources (contained resources) -->
												<td>
                                                    <img src="#imageResource" alt="an image"/>
												</td>
											</tr>
										</table>
									</div>
								</text>
							</section>
							<section>
								<title value="4. CLINICAL PARTICULARS"/>
								<code>
									<coding>
										<system value="http://spor.ema.europa.eu/v1/example-sections"/>
                               		 <code value="0000002223333"/>
                              		  <display value="clinical-particulars"/>
									</coding>
								</code>
								<!-- text is optional, if this is just a heading it may not be necessary -->
								<!--text></text-->
								<section>
									<title value="4.1 Therapeutic indications"/>
									<code>
										<coding>
											<system value="http://spor.ema.europa.eu/v1/example-sections"/>
                                 		    <code value="00000044444"/>
                                 			<display value="Therapeutic Indications"/>
                                        </coding>
                                    </code>
									<text>
										<status value="additional"/>
										<div xmlns="http://www.w3.org/1999/xhtml">
											<div>
												<p>Kalydeco tablets are indicated:</p>
											</div>
											<ul>
												<li>
													<p>As monotherapy for the treatment of adults, adolescents, and children aged 6 years and older and weighing 25 kg or more with cystic fibrosis (CF) who have an R117H CFTR mutation or one of the following gating (class III) mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R (see sections 4.4 and 5.1).</p>
												</li>
												<li>
													<p>In a combination regimen with tezacaftor/ivacaftor tablets for the treatment of adults, adolescents, and children aged 6 years and older with cystic fibrosis (CF) who are homozygous for the F508del mutation or who are heterozygous for the F508del mutation and have one of the following mutations in the CFTR gene: P67L, R117C, L206W, R352Q, A455E, D579G, 711+3A→G, S945L, S977F, R1070W, D1152H, 2789+5G→A, 3272-26A→G, and 3849+10kbC→T.</p>
												</li>
												<li>
													<p>In a combination regimen with ivacaftor /tezacaftor /elexacaftor tablets for the treatment of adults and adolescents aged 12 years and older with cystic fibrosis (CF) who are homozygous for the F508del mutation in the CFTR gene or heterozygous for F508del and have a minimal function (MF) mutation in the CFTR gene (see section 5.1).</p>
												</li>
											</ul>
										</div>
									</text>
								</section>
								<section>
									<title value="4.2 Posology and method of administration"/>
									<code>
										<coding>
											<system value="http://spor.ema.europa.eu/v1/example-sections"/>
                                  		  <code value="0000005555"/>
                                 		   <display value="Posology"/>
                                        </coding>
                                    </code>
									<text>
										<status value="additional"/>
										<div xmlns="http://www.w3.org/1999/xhtml">
											<div>
												<p>Kalydeco should only be prescribed by physicians with experience in the treatment of cystic fibrosis. If the patient's genotype is unknown, an accurate and validated genotyping method should be performed before starting treatment to confirm the presence of an indicated mutation in the CFTR gene (see section 4.1). The phase of the poly-T variant identified with the R117H mutation should be determined in accordance with local clinical recommendations.</p>
											</div>
										</div>
									</text>
								</section>
							</section>
							<!-- sections can repeat as necessary -->
						</Composition>
					</resource>
				</entry>
				<entry>
               <fullUrl value="urn:uuid:31ba7a75-e9a3-4751-b2a9-2547459acff7"/>
					<resource>
						<List>
							<!-- any id will do -->
                     	   <id value="SmPCProductsKalydeco2"/>
							<status value="current"/>
							<mode value="working"/>
							<entry>
								<item>
									<!-- Example of an absolute URL -->
									<!--reference value="https://pms-msfhir-r5-p2-sit.azurewebsites.net/MedicinalProductDefinition/600000450290"/-->
									<reference value="MedicinalProductDefinition/Kalydeco75"/>
									<!--reference value="urn:uuid:6916263f-f04d-4115-be23-b9a840e2f3e3"/-->
									<display value="Kalydeco 75 mg film-coated tablets"/>
									<!-- todo how refs will work -->
								</item>
							</entry>
							<entry>
								<item>
									<reference value="MedicinalProductDefinition/Kalydeco150"/>
									<!--reference value="urn:uuid:6916263f-f04d-4115-be23-b9a840e2f3e4"/-->
									<display value="Kalydeco 150 mg film-coated tablets"/>
								</item>
							</entry>
						</List>
					</resource>
				</entry>
			</Bundle>
		</resource>
	</entry>
</Bundle>